| __timestamp | Bausch Health Companies Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2254600000 | 2613100000 |
| Thursday, January 1, 2015 | 2645000000 | 2891500000 |
| Friday, January 1, 2016 | 2611000000 | 3228800000 |
| Sunday, January 1, 2017 | 2548000000 | 2966700000 |
| Monday, January 1, 2018 | 2351000000 | 2900200000 |
| Tuesday, January 1, 2019 | 2350000000 | 3064100000 |
| Wednesday, January 1, 2020 | 2249000000 | 3248100000 |
| Friday, January 1, 2021 | 2394000000 | 2722500000 |
| Saturday, January 1, 2022 | 2364000000 | 2996200000 |
| Sunday, January 1, 2023 | 2559000000 | 2975200000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Perrigo Company plc and Bausch Health Companies Inc. from 2014 to 2023. Over this period, Perrigo consistently reported higher costs, peaking in 2020 with a 24% increase from 2014. Meanwhile, Bausch Health's cost of revenue remained relatively stable, with a slight dip in 2020, followed by a 14% rise by 2023. These trends highlight Perrigo's aggressive growth strategy, while Bausch Health maintains a more conservative approach. Such insights are invaluable for those looking to understand the financial dynamics of these industry giants. As the pharmaceutical landscape continues to shift, monitoring these cost trends will be essential for predicting future performance.
Eli Lilly and Company vs Perrigo Company plc: Efficiency in Cost of Revenue Explored
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Grifols, S.A. and Perrigo Company plc
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
Key Insights on Gross Profit: Perrigo Company plc vs Bausch Health Companies Inc.
Analyzing Cost of Revenue: Perrigo Company plc and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Bausch Health Companies Inc.
Cost of Revenue Trends: Perrigo Company plc vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Perrigo Company plc vs MiMedx Group, Inc.
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Bausch Health Companies Inc. vs Mesoblast Limited